The clinical trial landscape has shifted as a result of COVID-19 and quality risk management techniques and tools have evolved by leaps and bounds over the last year. Best practices in RBQM are influencing clinical study methodology and decentralized trials, putting a spotlight on risk based data review including site and central monitoring.

DGE invites you to attend the 4^th Risk-Based Quality Management Summit and hear from industry experts on how elements of RBQM can be implemented individually and independently to great success, making clinical trials better, faster, cheaper, and safer for patients.

• Enable Smarter RBQM with Technology

• Review Newly Revised ICH E6(R3) and its Impact in Clinical Research

• Evaluate Key Success Factors for Adopting a QbD Methodology

• Predict and Avoid Common Pitfalls in Your RBQM Journey

• Acquire Talent With the Necessary Skills for RBQM Success

This conference is designed for pharmaceutical, biotech, and medical device professionals responsible for:

• RBM/RBQM

• Study Monitoring

• Central Monitoring/Site Monitoring

• Clinical Operations

• Clinical Research

• Clinical Quality

• Clinical Quality Assurance

• Clinical Compliance

• Clinical Outsourcing

• Data Management

• Data Science

• Global Clinical Trial Operations

• Regulatory Affairs

• Risk Evaluation